CN114591889A - 一种hek293t细胞的悬浮驯化方法及其在慢病毒生产中的应用 - Google Patents
一种hek293t细胞的悬浮驯化方法及其在慢病毒生产中的应用 Download PDFInfo
- Publication number
- CN114591889A CN114591889A CN202210356001.4A CN202210356001A CN114591889A CN 114591889 A CN114591889 A CN 114591889A CN 202210356001 A CN202210356001 A CN 202210356001A CN 114591889 A CN114591889 A CN 114591889A
- Authority
- CN
- China
- Prior art keywords
- cells
- cell
- culturing
- culture medium
- suspension
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000725 suspension Substances 0.000 title claims abstract description 51
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 31
- 238000000034 method Methods 0.000 title claims abstract description 25
- 241000713666 Lentivirus Species 0.000 title claims abstract description 21
- 239000001963 growth medium Substances 0.000 claims abstract description 51
- 239000002435 venom Substances 0.000 claims abstract description 7
- 210000001048 venom Anatomy 0.000 claims abstract description 7
- 231100000611 venom Toxicity 0.000 claims abstract description 7
- 238000012258 culturing Methods 0.000 claims description 64
- 238000005070 sampling Methods 0.000 claims description 46
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 35
- 230000000694 effects Effects 0.000 claims description 31
- 238000007865 diluting Methods 0.000 claims description 22
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 21
- 230000004083 survival effect Effects 0.000 claims description 21
- 239000002609 medium Substances 0.000 claims description 14
- 239000006285 cell suspension Substances 0.000 claims description 12
- 239000013612 plasmid Substances 0.000 claims description 10
- 230000003833 cell viability Effects 0.000 claims description 9
- 230000008014 freezing Effects 0.000 claims description 9
- 238000007710 freezing Methods 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 9
- 238000004806 packaging method and process Methods 0.000 claims description 7
- 239000006228 supernatant Substances 0.000 claims description 6
- 238000001890 transfection Methods 0.000 claims description 6
- MFBOGIVSZKQAPD-UHFFFAOYSA-M sodium butyrate Chemical compound [Na+].CCCC([O-])=O MFBOGIVSZKQAPD-UHFFFAOYSA-M 0.000 claims description 4
- 230000035899 viability Effects 0.000 claims description 4
- 238000005054 agglomeration Methods 0.000 claims description 3
- 230000002776 aggregation Effects 0.000 claims description 3
- 238000007664 blowing Methods 0.000 claims description 3
- 238000004113 cell culture Methods 0.000 claims description 3
- 238000011097 chromatography purification Methods 0.000 claims description 3
- 238000003306 harvesting Methods 0.000 claims description 3
- 238000005086 pumping Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 239000012096 transfection reagent Substances 0.000 claims description 3
- 239000008188 pellet Substances 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims 1
- 239000000306 component Substances 0.000 abstract description 8
- 230000008569 process Effects 0.000 abstract description 5
- 241001465754 Metazoa Species 0.000 abstract description 4
- 238000003908 quality control method Methods 0.000 abstract description 4
- 239000012535 impurity Substances 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 239000004017 serum-free culture medium Substances 0.000 abstract description 2
- 210000002966 serum Anatomy 0.000 description 4
- 238000013411 master cell bank Methods 0.000 description 3
- 241000700605 Viruses Species 0.000 description 2
- 230000001464 adherent effect Effects 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 238000004115 adherent culture Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000011278 co-treatment Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000010361 transduction Methods 0.000 description 1
- 230000026683 transduction Effects 0.000 description 1
- 238000003146 transient transfection Methods 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0684—Cells of the urinary tract or kidneys
- C12N5/0686—Kidney cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15041—Use of virus, viral particle or viral elements as a vector
- C12N2740/15043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15051—Methods of production or purification of viral material
- C12N2740/15052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/106—Plasmid DNA for vertebrates
- C12N2800/107—Plasmid DNA for vertebrates for mammalian
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210356001.4A CN114591889A (zh) | 2022-04-06 | 2022-04-06 | 一种hek293t细胞的悬浮驯化方法及其在慢病毒生产中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210356001.4A CN114591889A (zh) | 2022-04-06 | 2022-04-06 | 一种hek293t细胞的悬浮驯化方法及其在慢病毒生产中的应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114591889A true CN114591889A (zh) | 2022-06-07 |
Family
ID=81821348
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210356001.4A Pending CN114591889A (zh) | 2022-04-06 | 2022-04-06 | 一种hek293t细胞的悬浮驯化方法及其在慢病毒生产中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114591889A (zh) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109280636A (zh) * | 2017-07-21 | 2019-01-29 | 上海恒润达生生物科技有限公司 | 一种悬浮驯化293t细胞的方法 |
CN110713971A (zh) * | 2019-11-06 | 2020-01-21 | 深圳市菲鹏生物治疗股份有限公司 | 一种无血清悬浮培养型293t细胞、其制备方法以及病毒的包装方法 |
CN112430582A (zh) * | 2020-12-04 | 2021-03-02 | 北京艺妙神州医药科技有限公司 | 一种慢病毒稳定包装细胞系及其制备方法 |
CN113265425A (zh) * | 2021-05-08 | 2021-08-17 | 苏州博腾生物制药有限公司 | 基于悬浮细胞的car-cd19慢病毒制备工艺 |
CN113717927A (zh) * | 2021-08-31 | 2021-11-30 | 宜明(北京)细胞生物科技有限公司 | 一种hek-293细胞无血清和悬浮培养的制备方法及其应用 |
CN113981007A (zh) * | 2021-10-27 | 2022-01-28 | 苏州博腾生物制药有限公司 | 基于hek293t克隆筛选的用于高滴度慢病毒生产的悬浮驯化方法 |
-
2022
- 2022-04-06 CN CN202210356001.4A patent/CN114591889A/zh active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109280636A (zh) * | 2017-07-21 | 2019-01-29 | 上海恒润达生生物科技有限公司 | 一种悬浮驯化293t细胞的方法 |
CN110713971A (zh) * | 2019-11-06 | 2020-01-21 | 深圳市菲鹏生物治疗股份有限公司 | 一种无血清悬浮培养型293t细胞、其制备方法以及病毒的包装方法 |
CN112430582A (zh) * | 2020-12-04 | 2021-03-02 | 北京艺妙神州医药科技有限公司 | 一种慢病毒稳定包装细胞系及其制备方法 |
CN113265425A (zh) * | 2021-05-08 | 2021-08-17 | 苏州博腾生物制药有限公司 | 基于悬浮细胞的car-cd19慢病毒制备工艺 |
CN113717927A (zh) * | 2021-08-31 | 2021-11-30 | 宜明(北京)细胞生物科技有限公司 | 一种hek-293细胞无血清和悬浮培养的制备方法及其应用 |
CN113981007A (zh) * | 2021-10-27 | 2022-01-28 | 苏州博腾生物制药有限公司 | 基于hek293t克隆筛选的用于高滴度慢病毒生产的悬浮驯化方法 |
Non-Patent Citations (2)
Title |
---|
井莲娜 等: "无血清培养基悬浮培养BHK21 细胞驯化的研究" * |
唐取来 等: "机械搅拌式生物反应器悬浮培养293T 细胞生产慢病毒的工艺" * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113604425B (zh) | 一种适应无血清培养基环境的wayne293 lvpro细胞及其应用 | |
US11629338B2 (en) | Method for acclimating and suspending Vero and second order production process for virus | |
CN113717927B (zh) | 一种hek-293细胞无血清和悬浮培养的制备方法及其应用 | |
CN114317444B (zh) | 肠癌类器官培养液、培养试剂组合及培养方法 | |
CN113215193B (zh) | 小分子化合物提高基因敲除和碱基编辑系统活性的方法及其应用方法 | |
CN113444678A (zh) | 制备单细胞核悬液的方法、单细胞测序方法及试剂盒 | |
CN114317405A (zh) | 无血清全悬浮培养型f81细胞系及其构建方法与应用 | |
CN114480248A (zh) | 一种甘蔗茎组织原生质体的制备方法和应用 | |
CN115074310A (zh) | 基于同一肺脏组织样本同时进行单细胞悬液及单细胞核悬液制备的方法及应用 | |
CN114591889A (zh) | 一种hek293t细胞的悬浮驯化方法及其在慢病毒生产中的应用 | |
CN109666646A (zh) | 一种cd163基因编辑的猪胚胎成纤维细胞系的制备及应用 | |
WO2024077899A1 (zh) | 一种拟南芥叶片样本组织解离液及解离方法 | |
CN115747137B (zh) | Hek293单克隆细胞群的培养方法 | |
CN107236763A (zh) | 一种基于流式细胞术的构建基因敲除细胞系的方法 | |
CN108004204B (zh) | 一种高通量筛选优质卵母细胞的方法 | |
CN114703173B (zh) | 一种λ噬菌体DNA提取试剂盒及提取方法 | |
CN108753703B (zh) | 一种牙鲆胚胎肌卫星细胞系建立方法 | |
CN115418342A (zh) | 一种鱼组织单细胞悬液及其制备方法 | |
CN114277093A (zh) | 一种提取植物细胞核的方法 | |
WO2021073122A1 (zh) | 一种获得水稻叶鞘原生质体转化基因模块和线路的方法 | |
CN110396496B (zh) | 一种鸭小肠上皮细胞的培养方法及应用 | |
CN109880793B (zh) | 一种青年猪胰岛细胞培养基及其使用方法 | |
CN112111452B (zh) | 一种分离纯化真核细胞核糖体并用于体外翻译的方法 | |
CN111748516B (zh) | 一种成团细胞悬液快速优化制备悬浮细胞的方法 | |
Roos | Experimental and Technological Applications of Cell-Cell Fusion: An Overview |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Chen Zejian Inventor after: Hu Minghai Inventor after: Zhou Wenting Inventor after: Xiong Zichen Inventor after: Wu Shanshan Inventor after: Jiang Juling Inventor before: Chen Zejian Inventor before: Zhou Wenting Inventor before: Xiong Zichen Inventor before: Wu Shanshan Inventor before: Jiang Juling |
|
CB03 | Change of inventor or designer information | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220607 |
|
RJ01 | Rejection of invention patent application after publication |